Q4 2022 Holdings
Filed 2023-02-08 | 7 holdings | $74.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $25.7M | 2,220,034 | 34.6% |
| Kinnate Biopharma, Inc. | Common Stock | 49705R105 | $13.5M | 2,207,772 | 18.1% |
| Centessa Pharmaceuticals plc(CNTA) | Ordinary Shares | 152309100 | $12.2M | 3,931,818 | 16.4% |
| Allogene Therapeutics, Inc.(ALLO) | Common Stock | 019770106 | $11.3M | 1,798,163 | 15.2% |
| Kronos Bio, Inc.(KRON1USD) | Common Stock | 50107A104 | $4.5M | 2,765,314 | 6.0% |
| LianBio | Ordinary Shares | 53000N108 | $3.7M | 2,282,084 | 5.0% |
| Praxis Precision Medicines, Inc. | Common Stock | 74006W108 | $3.5M | 1,469,665 | 4.7% |